New hope for brain tumor patients: experimental drug targets recurrent meningioma
NCT ID NCT07533942
First seen Apr 17, 2026 · Last updated May 09, 2026 · Updated 4 times
Summary
This study tests an experimental drug called JZP3507 in 30 adults with recurrent grade 2 or 3 meningioma, a type of brain tumor. Participants take the drug orally to see if it can shrink or control the tumor. The goal is to find a new treatment option for people who have not responded to standard therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Louisiana State University
New Orleans, Louisiana, 70112, United States
-
Mass General
Boston, Massachusetts, 02114, United States
-
NYU- Langone Health
New York, New York, 10016, United States
-
Sutter Health
San Francisco, California, 94109, United States
-
University of Utah - Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
Conditions
Explore the condition pages connected to this study.